Sirtuin modulator 1

A SIRT1 activator

此产品仅用于科学研究，我们不为任何个人用途提供产品和服务

库存: 现货

可选规格

包装

价格

促销价

数量
1mg

￥700.00

560.00

- +
5mg

￥1412.00

1130.00

- +
10mg

￥2437.00

1950.00

- +
50mg

￥7275.00

5820.00

- +
100mg

￥12287.00

9830.00

- +

已选 0 种 0 瓶

金额: ￥0.00

首页收藏

Background

SRT 3025 is an activator of sirtuin 1 (SIRT1).^1,2,3 It increases SIRT1 levels in, and inhibits RANKL-induced osteoclastogenesis of, mouse bone marrow-derived macrophages (BMDMs) when used at a concentration of 2 ?M.¹ SRT 3025 inhibits the proliferation of SU.86.86 pancreatic adenocarcinoma cells (IC₅₀ = 0.98 ?M).² It decreases plasma levels of LDL, VLDL, and total cholesterol in ApoE^-/- mice fed a high-cholesterol diet when administered at a dose of 3.18 g/kg.³

1.Gurt, I., Artsi, H., Cohen-Kfir, E., et al.The Sirt1 activators SRT2183 and SRT3025 Inhibit RANKL-induced osteoclastogenesis in bone marrow-derived macrophages and down-regulate Sirt3 in Sirt1 null cellsPLoS One10(7)e0134391(2015) 2.Chini, C.C.S., Espindola-Netto, J.M., Mondal, G., et al.SIRT1-activating compounds (STAC) negatively regulate pancreatic cancer cell growth and viability through a SIRT1 lysosomal-dependent pathwayClin. Cancer Res.22(10)2496-2507(2015) 3.Miranda, M.X., van Tits, L.J., Lohmann, C., et al.The Sirt1 activator SRT3025 provides atheroprotection in Apoe-/- mice by reducing hepatic Pcsk9 secretion and enhancing Ldlr expressionEur. Heart J.36(1)51-59(2015)